| | | | | |
| €27,0857 | -0,72% | €240,28M | €7,56K | |
DBL DOUBLELINE OPPORTUNISTIC CREDIT FUND | €12,0609 | +0,14% | €239,99M | €17,36K | |
TSI TCW Strategic Income Fund, Inc. | €3,7605 | +0,23% | €239,59M | €46,52K | |
PAII Pyrophyte Acquisition Corp. II | €8,8101 | +0,15% | €239,17M | €5,996 | |
| €12,2579 | +2,21% | €239,05M | €64,59K | |
YDES YD Bio Limited Ordinary Shares | €3,8119 | -4,51% | €239,05M | €3,64K | |
XCBE X3 Acquisition Corp. Ltd. Class A Ordinary Shares | €8,6045 | +0,55% | €238,75M | €5,11K | |
RWAY Runway Growth Finance Corp. Common Stock | €5,5962 | -0,56% | €238,73M | €55,74K | |
JILL J.Jill, Inc. Common Stock | €16,8245 | -1,84% | €238,72M | €3,96K | |
LCTX Lineage Cell Therapeutics, Inc. | €0,94654 | +1,38% | €238,30M | €181,26K | |
AXIN Axiom Intelligence Acquisition Corp 1 Class A Ordinary Shares | €8,8358 | -0,05% | €238,23M | €6,50K | |
ACV Virtus Diversified Income & Convertible Fund | €22,6930 | +0,12% | €238,21M | €14,24K | |
ALXO ALX Oncology Holdings Inc. Common Stock | €1,7089 | +0,25% | €238,08M | €88,37K | |
| €1,2121 | +1,07% | €237,99M | €30,91K | |
YSG Yatsen Holding Limited American Depositary Shares, each representing twenty (20) Class A Ordinary Shares | €2,5415 | -1,10% | €237,84M | €11,11K | |
